ClearBridge Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580M Buy
483,528
+16,849
+4% +$17.2M 0.48% 50
2026
Q1
$429M Buy
466,679
+88,953
+24% +$90.2M 0.37% 70
2025
Q4
$406M Sell
377,726
-5,394
-1% -$5.16M 0.33% 78
2025
Q3
$292M Sell
383,120
-539,473
-58% -$401M 0.22% 107
2025
Q2
$719M Sell
922,593
-95,094
-9% -$73.9M 0.58% 39
2025
Q1
$841M Sell
1,017,687
-76,409
-7% -$63.6M 0.73% 25
2024
Q4
$845M Sell
1,094,096
-67,578
-6% -$56M 0.68% 24
2024
Q3
$1.03B Buy
1,161,674
+29,707
+3% +$26.7M 0.81% 20
2024
Q2
$1.02B Sell
1,131,967
-914
-0.1% -$731K 0.83% 18
2024
Q1
$881M Buy
1,132,881
+161,918
+17% +$115M 0.7% 29
2023
Q4
$566M Buy
970,963
+19,976
+2% +$11.7M 0.49% 57
2023
Q3
$511M Sell
950,987
-12,260
-1% -$6.32M 0.49% 54
2023
Q2
$452M Sell
963,247
-10,303
-1% -$4.32M 0.41% 67
2023
Q1
$334M Buy
973,550
+667,410
+218% +$225M 0.32% 87
2022
Q4
$112M Sell
306,140
-1,015
-0.3% -$360K 0.11% 190
2022
Q3
$99.3M Sell
307,155
-2,678
-0.9% -$848K 0.1% 193
2022
Q2
$100M Buy
309,833
+530
+0.2% +$159K 0.09% 201
2022
Q1
$88.6M Sell
309,303
-61,169
-17% -$15.7M 0.07% 266
2021
Q4
$102M Sell
370,472
-134,159
-27% -$34M 0.07% 243
2021
Q3
$117M Sell
504,631
-21,197
-4% -$5.23M 0.08% 210
2021
Q2
$121M Sell
525,828
-39,365
-7% -$7.91M 0.08% 211
2021
Q1
$106M Buy
565,193
+43,014
+8% +$8.41M 0.08% 212
2020
Q4
$88.2M Buy
522,179
+484,411
+1,283% +$72.3M 0.07% 224
2020
Q3
$5.59M Buy
37,768
+6,011
+19% +$930K ﹤0.01% 571
2020
Q2
$5.21M Buy
31,757
+23,909
+305% +$3.67M ﹤0.01% 555
2020
Q1
$1.09M Hold
7,848
﹤0.01% 616
2019
Q4
$1.04M Hold
7,848
﹤0.01% 653
2019
Q3
$878K Hold
7,848
﹤0.01% 668
2019
Q2
$869K Hold
7,848
﹤0.01% 670
2019
Q1
$1.02M Hold
7,848
﹤0.01% 677
2018
Q4
$908K Hold
7,848
﹤0.01% 696
2018
Q3
$842K Hold
7,848
﹤0.01% 737
2018
Q2
$670K Hold
7,848
﹤0.01% 670
2018
Q1
$607K Hold
7,848
﹤0.01% 671
2017
Q4
$663K Sell
7,848
-814
-9% -$69.3K ﹤0.01% 670
2017
Q3
$741K Sell
8,662
-4,959
-36% -$407K ﹤0.01% 656
2017
Q2
$1.12M Hold
13,621
﹤0.01% 621
2017
Q1
$1.15M Sell
13,621
-51
-0.4% -$4.08K ﹤0.01% 664
2016
Q4
$1.01M Sell
13,672
-365
-3% -$27.2K ﹤0.01% 680
2016
Q3
$1.13M Buy
14,037
+51
+0.4% +$4.08K ﹤0.01% 668
2016
Q2
$1.1M Sell
13,986
-3,600
-20% -$271K ﹤0.01% 676
2016
Q1
$1.27M Sell
17,586
-3,600
-17% -$272K ﹤0.01% 669
2015
Q4
$1.78M Sell
21,186
-1,570
-7% -$130K ﹤0.01% 658
2015
Q3
$1.9M Buy
22,756
+3,400
+18% +$287K ﹤0.01% 660
2015
Q2
$1.62M Sell
19,356
-400
-2% -$30.5K ﹤0.01% 696
2015
Q1
$1.44M Sell
19,756
-500
-2% -$35.6K ﹤0.01% 726
2014
Q4
$1.4M Sell
20,256
-225
-1% -$15.2K ﹤0.01% 740
2014
Q3
$1.33M Sell
20,481
-119
-0.6% -$7.53K ﹤0.01% 742
2014
Q2
$1.28M Sell
20,600
-525
-2% -$31.3K ﹤0.01% 710
2014
Q1
$1.24M Sell
21,125
-592
-3% -$33K ﹤0.01% 716
2013
Q4
$1.11M Sell
21,717
-3,154
-13% -$158K ﹤0.01% 709
2013
Q3
$1.25M Buy
24,871
+41
+0.2% +$2.15K ﹤0.01% 680
2013
Q2
$1.22M Buy
+24,830
New +$1.35M ﹤0.01% 667

Other funds holding LLY

ClearBridge Investments's LLY Position: Q2 2026 in Review

ClearBridge Investments increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $17.2M and bringing the position to 483,528 shares worth $580M. The position accounts for 0.48% of the portfolio, ranked #50.

ClearBridge Investments first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.03B in Q3 2024. 3,955 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ClearBridge Investments held 483,528 shares of Eli Lilly worth $580M as of Q2 2026.
  • ClearBridge Investments bought 16,849 Eli Lilly shares in Q2 2026, an estimated $17.2M.
  • Eli Lilly made up 0.48% of ClearBridge Investments's portfolio in Q2 2026, its #50 holding.
  • ClearBridge Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • ClearBridge Investments's Eli Lilly position peaked at $1.03B in Q3 2024.
  • 3,955 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.